TCRX: Nilai perusahaan marang bathi resik tscan.com

TScan Therapeutics, Inc. - logo grafis emiten TCRX

TScan Therapeutics (TCRX) develops personalized cell therapies to combat skin and lung tumors using the TargetScan system. The price action of the securities reflects the -0.10 metric. Research is based in US laboratories, where methods for detecting hidden targets are being refined. However, a high burn rate and the probability of side effects during testing render the project's commercial success a long-term hypothesis.

Koefisien rega marang bathi: TScan (TCRX) kanggo 04.07.2022 - 10.11.2026

Rincian metrik komprehensif lan analitis TScan Therapeutics Inc (TCRX)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega TScan|TCRX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar TScan Therapeutics, Inc.|TCRX - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham TScan Therapeutics|TCRX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku tscan.com|TCRX - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi TScan Therapeutics|TCRX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal TScan|TCRX - Gunggung utang perusahaan|Utang marang modal buku TScan Therapeutics, Inc.|TCRX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak TScan Therapeutics|Indikator likuiditas cepet tscan.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
TCRX - Bathi resik|Proyeksi bathi mangsa ngarep TScan Therapeutics|TCRX - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep TScan|TCRX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan TScan Therapeutics, Inc.|TCRX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan TScan Therapeutics|TCRX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan tscan.com|TCRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep TScan Therapeutics
Analisis umum perusahaan:tscan.com, TCRX
Barang unggulan TScan Therapeutics, Inc.

TScan Therapeutics (TCRX) is developing capital-intensive cell therapy technologies, leveraging its robust R&D potential and academic staff. The P/E ratio here measures the market value of each unit of profit, reflecting the extent of the premium paid for future success or the risk of liquidity shortages; therefore, the company's P/E history serves as an indicator of capitalization resilience to volatility, helping investors determine the fair value assessment of the assets.

Analisis perusahaan pesaing

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (Ascentage)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis (PSNL) - Rasio rega marang bathi|Erasca Inc - Nilai perusahaan marang bathi resik|DCTH (Delcath) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Corp YMAB|Koefisien rega marang bathi AURA (Aura Biosciences, Inc.)|Rasio rega pasar marang bathi resik CADL|Rasio rega marang bathi Accuray ARAY|Periode bali modal bisnis SELLAS Life Sciences Group, Inc. (SLS)|Actuate Therapeutics, Inc - Pangali P/E|Citius Oncology Inc (CTOR) - Koefisien rega marang bathi|HURA: Pangali P/E|protaratx.com (TARA) - Pangali P/E|Rasio rega marang bathi Fate Therapeutics|Pangali rega marang bathi WHWK (Aadi Bio)|Koefisien rega marang bathi CSBR (Champions Oncology)|XBIT (xbiotech.com) - Nilai perusahaan marang bathi resik|CEL-SCI - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik OSTX (ostherapies.com)|Radiopharm Theranostics - Pangali P/E|Nilai perusahaan marang bathi resik ARTV (Artiva Biotherapeutics, Inc.)|ANL: Pangali P/E|Kapitalisasi marang bathi Veru Corporation (VERU)|Rasio rega marang bathi Tempest Therapeutics|XLO: Nilai perusahaan marang bathi resik|Pangali P/E RENB|Pangali P/E muraloncology.com (MURA)|Rasio rega marang bathi Kairos Pharma KAPA|OKUR (OnKure Therapeutics, Inc.) - Kapitalisasi marang bathi resik|CytoMed - Pangali P/E|Kapitalisasi marang bathi Curis, Inc.|APLM (apollomicsinc.com) - Koefisien rega marang bathi|Tharimmune Inc (THAR) - Pangali P/E|Koefisien rega marang bathi ADVB|GNPX (Genprex Inc) - Rasio rega pasar marang bathi resik|Pangali P/E CLDI|Periode bali modal bisnis sunshinebiopharma.com|Pangali P/E XBIO (Xenetic Biosciences, Inc.)|SLRX - Koefisien rega marang bathi|PPBT - Rasio rega marang bathi|Periode bali modal bisnis American Oncology Network AONC|BGNE (BeiGene, Ltd.) - Koefisien rega marang bathi|CKPT: Rasio rega pasar marang bathi resik|ELEV (Elevation Oncology) - Pangali P/E|Koefisien rega marang bathi iCAD Corp (ICAD)|Rasio rega marang bathi Ikena Oncology, Inc. (IKNA)|NTBL (Notable Labs Corp) - Nilai perusahaan marang bathi resik|Viracta Therapeutics, Inc. - Koefisien rega marang bathi|MOR: Pangali rega marang bathi|NAYA Biosciences Inc. - Pangali P/E|Ascentage Pharma Group International (AAPGV) - Koefisien rega marang bathi